Matches in Nanopublications for { ?s ?p "[B-cell chronic lymphocytic leukemia (B-CLL) samples were screened for alterations in multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and disrupted in B-cell malignancy (DBM) (13q14) by using polymerase chain reaction-based assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP219996.RAjgbEElhX0VrMzeROgJc1AQI91QGi2GCU0kZmbWWFTm0130_assertion description "[B-cell chronic lymphocytic leukemia (B-CLL) samples were screened for alterations in multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and disrupted in B-cell malignancy (DBM) (13q14) by using polymerase chain reaction-based assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219996.RAjgbEElhX0VrMzeROgJc1AQI91QGi2GCU0kZmbWWFTm0130_provenance.
- NP698890.RAyE9axT0M2sIM0G9x-1vXuM7X1WWLFkPwKCbx4sC37PM130_assertion description "[B-cell chronic lymphocytic leukemia (B-CLL) samples were screened for alterations in multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and disrupted in B-cell malignancy (DBM) (13q14) by using polymerase chain reaction-based assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP698890.RAyE9axT0M2sIM0G9x-1vXuM7X1WWLFkPwKCbx4sC37PM130_provenance.
- NP306810.RAFizDmoAMQyeOmZ61PfxfZBtAnZDuEvOHNsAbnyni0Zw130_assertion description "[B-cell chronic lymphocytic leukemia (B-CLL) samples were screened for alterations in multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and disrupted in B-cell malignancy (DBM) (13q14) by using polymerase chain reaction-based assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306810.RAFizDmoAMQyeOmZ61PfxfZBtAnZDuEvOHNsAbnyni0Zw130_provenance.
- NP1313115.RA1HudY0hDSegCzqQ-QZxo6vSWYeSpLIjQAluaeCLg92s130_assertion description "[B-cell chronic lymphocytic leukemia (B-CLL) samples were screened for alterations in multiple tumor suppressor genes (p53 (17p13), p16INK4 (9p21), and disrupted in B-cell malignancy (DBM) (13q14) by using polymerase chain reaction-based assays.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313115.RA1HudY0hDSegCzqQ-QZxo6vSWYeSpLIjQAluaeCLg92s130_provenance.